RI-MUHC success in grant competition for transplantation research
Researchers awarded funds from the Canadian Donation and Transplantation Research Program for innovative research projects in organ and tissue transplantationSource: CDTRP and RI-MUHC. Announced on July 13, the Canadian Donation and Transplantation Research Program (CDTRP) will fund three new projects led by organ and tissue transplant researchers at the Research Institute of the McGill University Health Centre (RI-MUHC) and the MUHC.(L-R) CDTRP grant recipients from the Research Institute of the MUHC: Steven Paraskevas, Amine Benmassaoud and Tania Janaudis-FerreiraSince 2012 the CDTRP has supported research and innovation that addresses barriers within the fields of donation and transplantation, with the ultimate goal of advancing long-term health outcomes and quality of life for Canadian transplant patients. The CDTRP Research Innovation Grant competition supports new peer-reviewed pilot research projects that align with CDTRP’s One-Transplant-for-Life vision, which is to fulfill every donor opportunity and turn transplant into a cure. This year’s results were exceptional for the RI-MUHC, as three of the four grants issued in the Research Innovation category were awarded to proposals from our research community.Congratulations to the awardees!Steven Paraskevas, MD, PhD, scientist in the Metabolic Disorders and Complications Program and Corinne A Hoesli, MD, for the project “Making every pancreatic islet count – engineering a vascularized transplantation system to treat type 1 diabetes”Amine Benmassaoud, MD, associate investigator in the Cardiovascular Health Across the Lifespan Program, for the project “Does a 4-week prehabilitation program improve frailty in patients with cirrhosis undergoing liver transplantation? A feasibility trial”Tania Janaudis-Ferreira, PhD, junior scientist in the Translational Research in Respiratory Diseases Program and trainee Nicholas Bourgeois for the project “Virtual home-based pre-habilitation program in lung transplant candidates”July 22, 2021
RI-MUHC team identifies potential diagnostic biomarker for pancreatic cancer
Study demonstrates that regenerative protein 3A/3B promotes a newly recognized precursor of pancreatic...
RI-MUHC trainee wins award at Canadian Society of Nephrology meeting
Congratulations to Tho-Alfakar Al-Aubodah!
Does the COVID-19 vaccine work for people living with HIV?
RI-MUHC scientist Dr. Cecilia Costiniuk is co-principal investigator in a new national study that hopes to answer critical questions around the...
How does the hunger-suppressing hormone leptin cross the blood-brain barrier?
Specialized cells called pericytes play a key role, reveals new work from researchers at the RI-MUHC
Recurrent miscarriage: what if the cause is genetic?
Next-generation gene sequencing may provide answers for some women dealing with recurrent pregnancy loss and prevent further miscarriages
New study paves the way to novel treatment for Triple Negative Breast Cancer
A team of researchers at the RI-MUHC found two cellular pathways involved in TNBC tumour development...
RI-MUHC study explores how to overcome the resistance of bladder tumours to radiation therapy
Work published in Nature Communications demonstrates a...
Tracking the emerging COVID-19 variants of concern in Canada
RI-MUHC researcher Ciriaco Piccirillo takes a leading role in Canada’s new Coronavirus Variants Rapid Response Network
RI-MUHC researcher receives inaugural Canadian Cancer Society award
Congratulations to Dr. Julia Valdemarin Burnier!